aaiPharma Inc., of Wilmington, N.C., appointed Matthew Czajkowski executive vice president and chief financial officer.
airPharma, of Overland Park, Kan., appointed Peter Higuchi vice president, corporate development, and Ed Mitchell vice president, product development.
Anadys Pharmaceuticals Inc., of San Diego, appointed Douglas Richman chairman of its clinical and scientific advisory board.
Barrier Therapeutics Inc., of Princeton, N.J., appointed Robert Campbell lead director of its board.
Bioenvision Inc., of New York, appointed Robert Bradbury UK sales manager, and Katy Porter medical information manager.
Callisto Pharmaceuticals Inc., of New York, appointed Paula Craft vice president, regulatory affairs.
Cepheid Inc., of Sunnyvale, Calif., appointed Humberto Reyes senior vice president of operations.
Cytos Biotechnology AG, of Zurich, Switzerland, appointed Hans Stocker executive vice president regulatory affairs.
ForteBio Inc., of Menlo Park, Calif., appointed Scott Lockard vice president, engineering.
Galapagos Genomics NV, of Mechelen, Belgium, appointed Graham Dixon chief scientific officer.
Gene Logic Inc., of Gaithersburg, Md., appointed Frank Douglas to its board.